Marketing Manager, Cold&Flu
I was leading C&F portfolio with ACC and Broncho-Munal as focus brandsManaged to keep Broncho-Munal market share stable after Feb'2022 thanks to re-focus of its go-to-market model towards pure medical approach and despite of the highly competitive category with mostly local Russian players who were able to use all promo channels including media promo